These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 3638135

  • 1. Enhanced specificity of immunoblotting using radiolabeled antigen overlay: studies of blood coagulation factor XII and prekallikrein in plasma.
    Lämmle B, Berrettini M, Griffin JH.
    Anal Biochem; 1986 Jul; 156(1):118-25. PubMed ID: 3638135
    [Abstract] [Full Text] [Related]

  • 2. Immunoblotting studies of coagulation factor XII, plasma prekallikrein, and high molecular weight kininogen.
    Lämmle B, Berrettini M, Griffin JH.
    Semin Thromb Hemost; 1987 Jan; 13(1):106-14. PubMed ID: 3494310
    [Abstract] [Full Text] [Related]

  • 3. Mechanism of surface-mediated activation of bovine Factor XII and prekallikrein.
    Sugo T, Ohno Y, Shimada T, Kato H, Iwanaga S.
    Adv Exp Med Biol; 1983 Jan; 156():87-107. PubMed ID: 6602465
    [Abstract] [Full Text] [Related]

  • 4. [Determination of factor XII and plasma prekallikrein with chromozym PK].
    Stürzebecher J, Klessen C, Markwardt F.
    Z Med Lab Diagn; 1982 Oct; 23(5):306-11. PubMed ID: 6924817
    [No Abstract] [Full Text] [Related]

  • 5. Determination of Hageman factor (HG, factor XII) and plasma prekallikrein (Fletcher factor) by radioimmunoassays.
    Saito H.
    Adv Exp Med Biol; 1979 Oct; 120A():165-72. PubMed ID: 573961
    [Abstract] [Full Text] [Related]

  • 6. Quantitative immunoblotting assay of blood coagulation factor XII.
    Lämmle B, Berrettini M, Schwarz HP, Heeb MJ, Griffin JH.
    Thromb Res; 1986 Mar 15; 41(6):747-59. PubMed ID: 3085274
    [Abstract] [Full Text] [Related]

  • 7. [Contact coagulation factors].
    Kojima T, Saito H.
    Rinsho Byori; 1987 Apr 15; Spec No 70():79-87. PubMed ID: 3302400
    [No Abstract] [Full Text] [Related]

  • 8. Plasma prekallikrein, factor XII, antithrombin III, C1(-)-inhibitor and alpha 2-macroglobulin in critically ill patients with suspected disseminated intravascular coagulation (DIC).
    Lämmle B, Tran TH, Ritz R, Duckert F.
    Am J Clin Pathol; 1984 Oct 15; 82(4):396-404. PubMed ID: 6206713
    [Abstract] [Full Text] [Related]

  • 9. [Determination of factor XII, plasma prekallikrein and factor V in patients with thrombophilic states].
    Stürzebecher J, Huyke R, Vogel G.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984 Oct 15; 111(4):492-6. PubMed ID: 6083916
    [Abstract] [Full Text] [Related]

  • 10. A study of hemostasis in ischemic cerebrovascular disease: IV. A five year follow-up of some blood coagulation parameters also including fibrinopeptide A, factor XII and prekallikrein.
    Mettinger KL.
    Thromb Res; 1982 Jul 15; 27(2):155-60. PubMed ID: 6814002
    [Abstract] [Full Text] [Related]

  • 11. Factors XI and XII and prekallikrein in sick and healthy premature infants.
    Andrew M, Bhogal M, Karpatkin M.
    N Engl J Med; 1981 Nov 05; 305(19):1130-3. PubMed ID: 6912944
    [No Abstract] [Full Text] [Related]

  • 12. Acetylcysteine in rats: inhibition of activation of prekallikrein and factor XII--protection against dextran-induced blood pressure fall.
    Hoem NO, Briseid G.
    Pharmacol Toxicol; 1987 Feb 05; 60(2):140-4. PubMed ID: 2437551
    [Abstract] [Full Text] [Related]

  • 13. [Plasma kallikrein-kinin system in hypercoagulable state (author's transl)].
    Koie K, Kamiya T, Takamatsu J, Hayashi K, Saito H.
    Rinsho Ketsueki; 1980 Jun 05; 21(6):704-13. PubMed ID: 6450843
    [No Abstract] [Full Text] [Related]

  • 14. [Studies on plasma prekallikrein assay method with chromogenic substrates (S-2302)].
    Fukuda C, Iijima K, Nakamura K.
    Rinsho Byori; 1983 Feb 05; 31(2):219-22. PubMed ID: 6190027
    [No Abstract] [Full Text] [Related]

  • 15. Determination of prekallikrein using an amidolytic assay in plasma samples of critically ill patients.
    Kalter ES, Vlooswijk RA, Bouma BN.
    Acta Chir Scand Suppl; 1982 Feb 05; 509():43-7. PubMed ID: 6962618
    [No Abstract] [Full Text] [Related]

  • 16. Human plasma prekallikrein. Studies of its activation by activated factor XII and of its inactivation by diisopropyl phosphofluoridate.
    Bouma BN, Miles LA, Beretta G, Griffin JH.
    Biochemistry; 1980 Mar 18; 19(6):1151-60. PubMed ID: 6768384
    [Abstract] [Full Text] [Related]

  • 17. Reduction of contact factors in sickle cell disease.
    Gordon EM, Klein BL, Berman BW, Strandjord SE, Simon JE, Coccia PF.
    J Pediatr; 1985 Mar 18; 106(3):427-30. PubMed ID: 3844465
    [Abstract] [Full Text] [Related]

  • 18. A comparison of the effects of intravenous serotonin and dextran on the levels of factor XII, prekallikrein and plasminogen in rat plasma.
    Berstad J.
    Acta Pharmacol Toxicol (Copenh); 1980 Apr 18; 46(4):314-20. PubMed ID: 6154406
    [Abstract] [Full Text] [Related]

  • 19. Prekallikrein, HMW-kininogen and factor XII in various disease states.
    Deutsch E, Dragosics B, Kopsa H, Mannhalter C, Rainer H.
    Thromb Res; 1983 Jul 15; 31(2):351-64. PubMed ID: 6356459
    [Abstract] [Full Text] [Related]

  • 20. Analyses of factor XII, prekallikrein and kallikrein inhibitory capacity in patients with laboratory signs of DIC.
    Egberg N, Hellgren M.
    Scand J Clin Lab Invest Suppl; 1985 Jul 15; 178():25-9. PubMed ID: 3867118
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.